Group 1 - The semiconductor sector in Hong Kong is experiencing a continuous decline [1] - Hua Hong Semiconductor has dropped over 5% [1] - SMIC (Semiconductor Manufacturing International Corporation) has decreased nearly 4% [1] - Other companies such as Jingmen Semiconductor and Shanghai Fudan are also following the downward trend [1]

Group 1 - The Hong Kong stock market indices collectively declined, with technology and new energy vehicle stocks mostly falling, including significant drops in Li Auto and Xpeng Motors [1] - Li Auto's first pure electric SUV, the Li i8, was officially launched with a price range of 321,800 to 369,800 yuan, which is lower than the previously announced pre-sale price of 350,000 to 400,000 yuan [1] - Morgan Stanley's view indicates that the initial price of the Li i8 is slightly above expectations, with market focus on the competitiveness of hardware specifications, particularly for the Pro version [1] Group 2 - As of July 29, the latest valuation of the Hang Seng Technology Index ETF (513180) is 22.16 times, which is below 76% of the time since the index was launched on July 27, 2020, indicating a relative undervaluation [2] - The Hang Seng Technology Index is currently in a historically undervalued range, with characteristics of high elasticity and high growth, suggesting greater upward momentum [2] - Investors without a Hong Kong Stock Connect account can access Chinese AI core assets through the Hang Seng Technology Index ETF (513180) [2]

Core Viewpoint - Semiconductor stocks experienced a collective decline, with notable drops in companies such as Huahong Semiconductor, SMIC, ASMPT, and Shanghai Fudan, reflecting market sentiment influenced by Nvidia's recent actions and TSMC's performance [1] Group 1: Stock Performance - Huahong Semiconductor (01347) fell by 4.96%, closing at HKD 40.25 [1] - SMIC (00981) decreased by 4.12%, ending at HKD 51.15 [1] - ASMPT (00522) dropped by 2.74%, with a closing price of HKD 67.45 [1] - Shanghai Fudan (01385) saw a decline of 1.95%, closing at HKD 32.75 [1] Group 2: Nvidia and TSMC Developments - Nvidia has officially placed an order for 300,000 H20 chips with TSMC, supplementing an existing inventory of 600,000 to 700,000 H20 chips [1] - Reports indicate that Nvidia has informed clients of limited inventory for H20 AI chips and currently has no plans to restart production [1] Group 3: Market Sentiment and Future Outlook - Morgan Stanley noted that the release of H20 chips is beneficial for AI data center hosting companies but negatively impacts local semiconductor supply chain leaders like SMIC [1] - TSMC reported a net profit of nearly NT$398.3 billion in Q2 2025, a year-on-year increase of approximately 61%, marking a record high for quarterly net profit and the highest growth rate in three years [1] - Analysts suggest that the global semiconductor growth remains optimistic, with potential price increases from leading foundries and a positive outlook for Q2 performance [1]

7月30日，华虹半导体(01347)盘中下跌5.08%，截至10:15，报40.2元/股，成交5.61亿元。 华虹半导体有限公司是全球领先的特色工艺纯晶圆代工企业，专注于嵌入式/独立式非易失性存储器、 功率器件、模拟与电源管理和逻辑与射频等"8英寸+12英寸"特色工艺技术的持续创新。公司在上海金桥 和张江拥有三座8英寸晶圆厂和一座无锡的12英寸晶圆厂，月产能分别约18万片和7.5万片，提供多种1.0 微米至65/55纳米技术节点的可定制工艺选择，其产品广泛应用于新能源汽车、绿色能源、物联网等新 兴领域。 截至2025年一季报，华虹半导体营业总收入38.83亿元、净利润2691.82万元。 8月7日，华虹半导体将披露2025财年第二季度报。 本文源自：金融界 作者：行情君 ...

Group 1 - Chip stocks collectively declined, with Huahong Semiconductor down 4.96% to HKD 40.25, SMIC down 4.12% to HKD 51.15, ASMPT down 2.74% to HKD 67.45, and Shanghai Fudan down 1.95% to HKD 32.75 [1] - Nvidia has officially placed a new order for 300,000 H20 chips with TSMC, supplementing the existing inventory of 600,000 to 700,000 H20 chips [1] - Morgan Stanley indicated that the release of H20 is beneficial for AI data center hosting companies but negatively impacts local leading semiconductor supply chain companies like SMIC [1] Group 2 - TSMC achieved a net profit of nearly NT$398.3 billion in Q2 2025, a year-on-year increase of nearly 61%, marking a record high for quarterly net profit and the highest growth rate in nearly three years [1] - The global semiconductor growth trend remains optimistic, with leading foundries potentially initiating price increases and a positive outlook for Q2 performance [1] - Given the sustained high level of global computing power investment, the performance of industry chain companies is likely to continue to reflect this trend [1]

截至发稿，上海复旦(01385.HK)跌6.29%、华虹半导体(01347.HK)跌4.37%、中芯国际(00981.HK)跌 2.62%。 ...

Group 1 - The semiconductor market shows signs of recovery, with global market size reaching $589.8 billion in May, a month-on-month increase of 3.55% and a year-on-year increase of 20% [6][8] - Major domestic wafer foundries, including SMIC, Hua Hong, and JCET, report high capacity utilization rates, with SMIC increasing from 68.1% to 89.6% and Hua Hong exceeding 100% [9][11] - The overall performance of the semiconductor industry is improving, with significant growth in exports and production in the electronic information manufacturing sector [8][9] Group 2 - Despite positive trends in the upstream semiconductor market, the chip spot market remains sluggish, with many traders reporting decreased orders and inquiries [14][15] - The disparity in market conditions is evident, with some distributors experiencing growth while others face challenges due to supply-demand imbalances [16][17] - Different segments within the semiconductor industry are experiencing varied performance, with analog chip manufacturers like TI and ADI showing recovery, while power device and silicon carbide sectors remain under pressure [20][21] Group 3 - The tight capacity situation is attributed to factors such as tariff fluctuations, domestic demand recovery, and government subsidies, leading to increased orders for local foundries [24][25] - The overall sentiment in the semiconductor industry is mixed, with leading companies benefiting from high-end chip demand while smaller firms struggle with rising material costs and competitive pressures [22][25] - The industry is characterized by a "blind men touching an elephant" phenomenon, where different stakeholders have varying perceptions of the market situation [25]

Summary of Conference Call Records Industry and Companies Involved - **Industry**: Semiconductor - **Companies**: Huahong Semiconductor, ZTE Corporation Key Points and Arguments Huahong Semiconductor Performance - Q2 revenue declined due to one-time factors but strong downstream demand, especially in consumer and automotive electronics, is noted. Industrial segments also showed growth, with Q3 performance expected to exceed expectations [1][2] - The company received 10,000 equipment orders for 14nm expansion in the first half of the year, with an additional 5,000 to 10,000 expected in the second half [1][4] ZTE Corporation Performance - ZTE's N+2 and N+3 advanced process expansions faced short-term setbacks but are expected to recover in Q3. The N+2 expansion is anticipated to meet market expectations, while N+3's success depends on Mate 80 demand [1][4] - ZTE's Q1 revenue was projected to decline by 4% to 6% due to isolated incidents, but recovery is expected in Q3 [2][4] Market Expectations and Catalysts - Market expectations for Q2 performance are largely priced in, with significant focus on Q3 guidance from both companies. Continued optimism in consumer and automotive demand is anticipated [1][6] - Key catalysts for the second half include performance guidance, advanced process expansions, and potential capital operations, such as parent company capacity injections [1][5] Semiconductor Sector Overview - The semiconductor sector has underperformed, with a year-to-date increase in the single digits, while other segments have seen over 10% growth. The sector's trading volume is at a historical low of about 5% [7] - The foundry segment is particularly lagging, suggesting a need for investors to focus on innovative foundry opportunities [7] Long-term Projections - ZTE is projected to reach revenues of 30 billion by 2030, with advanced manufacturing contributing 20.6 billion and mature manufacturing 10.7 billion, maintaining a price advantage over TSMC [3][9] - Huahong aims for 100,000 pieces of advanced manufacturing capacity by the end of 2027, with projected revenues of 50 billion to 100 billion by 2030, also showing a competitive edge against TSMC [3][9] Investment Recommendations - Investors are advised to focus on the advanced manufacturing sector and consider companies in the advanced packaging segment, which are expanding capacity and collaborating with domestic GPU manufacturers [10][11] Additional Insights - The semiconductor sector's cash flow and performance metrics are currently at low historical levels, indicating potential investment opportunities in undervalued segments [7][9] This summary encapsulates the essential insights from the conference call records, highlighting the performance, expectations, and strategic directions of Huahong Semiconductor and ZTE Corporation within the semiconductor industry.

Market Overview - The market experienced a rotation with strong performances in pharmaceuticals, real estate, and semiconductors throughout the day, indicating a lack of new hot topics for trading [1] - There was significant buying activity in the Sci-Tech Innovation Board, particularly in semiconductors, with stocks like Cambrian and Maolai Optical seeing gains of over 10% [1] - The overall market sentiment suggests a slow upward trend, with a trading volume exceeding 1.8 trillion, indicating a bull market atmosphere despite some stocks underperforming [1][2] Sector Performance - The technology sector, particularly semiconductors, is expected to lead the market, with the Sci-Tech 50 index rising by 2% after lagging behind other indices [3] - There is potential for the technology rally to extend beyond semiconductors to other segments such as AI and robotics, which have been dormant but are anticipated to benefit from future positive developments [4] - Conversely, traditional sectors like liquor, represented by cyclical stocks, are currently underperforming, with little market expectation for an upcoming important meeting [5] Investment Strategy - Investors are advised to avoid chasing high-profile stocks like those in Hainan and Mengtou, as these have already been priced in and may not yield further gains [2] - The current market is characterized by structural opportunities, and there is no need for panic about missing out on the bull market, as the focus should be on disciplined investment strategies [2] - The future of stocks like Cambrian raises questions about whether the recent interest is a one-time event or the beginning of a longer-term trend, with potential catalysts in AI and robotics to watch for [6]

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index dropping over 1%, ending a five-day winning streak, closing at 25,388.35 points, down 1.09% or 278.83 points, with a total turnover of 281.77 billion HKD [1] - Despite the decline, the Hang Seng Index saw a weekly increase of 2.27%, while the Hang Seng China Enterprises Index and the Hang Seng Tech Index rose by 1.83% and 2.51% respectively [1] Blue Chip Performance - WuXi Biologics (02269) led the blue-chip stocks, rising 5.53% to 31.5 HKD, contributing 9.65 points to the Hang Seng Index, following a profit warning indicating a projected 16% revenue growth in the first half of 2025 [2] - Other notable blue-chip performances included SMIC (00981) up 4.98%, Nongfu Spring (09633) up 3.56%, while New Oriental (09901) and Shenzhou International (02313) saw declines of 3.36% and 2.94% respectively [2] Sector Highlights - Large tech stocks generally declined, with Alibaba down nearly 2% and Tencent over 1% [3] - Semiconductor stocks saw a rally, with Hua Hong Semiconductor rising 9% and SMIC up nearly 5% [3] - The pharmaceutical sector experienced gains, driven by a shift towards value assessment in drug procurement, with notable increases in stocks like Kanglong Chemical (03759) up 7.71% and Zhaoyan New Drug (06127) up 7.02% [4] - Airline stocks were active, with China Eastern Airlines (00670) up 3.69% and Air China (00753) up 3.68%, supported by strong summer travel demand [6][7] Regulatory Developments - The National Healthcare Security Administration announced changes to the 11th batch of centralized procurement, moving away from a simple lowest price reference, which is expected to curb vicious price competition and promote a shift towards value-based competition in the pharmaceutical industry [5] - The introduction of new policies aimed at supporting innovative drugs and medical devices was discussed in a recent meeting, indicating a focus on enhancing the clinical application of high-level technological innovations [5] Notable Stock Movements - Valiant Biopharma (09887) saw a significant increase of 91.71% on its debut, closing at 67.1 HKD, following a successful IPO [9] - Jihong Holdings (02603) rose 15.31% after announcing a projected net profit increase of 97.25% to 108.21% for the first half of 2025 [10] - COSCO Shipping Ports (01199) reached a new high, up 9.31%, amid reports of potential acquisitions of port assets [11] - Kintor Pharmaceutical (00148) announced a profit warning, leading to an 8.29% increase in stock price, with expected profits rising over 70% [12] - Lingbao Gold (03330) also saw gains, up 5.89%, with projected revenue growth of 75% to 85% for the first half of 2025 [13]